Compare BIO-TECHNE Corp (TECH) vs Upwork Inc (UPWK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs Upwork Inc — how do they compare? BIO-TECHNE Corp trades at $72.46 (market cap $11.37B), while Upwork Inc trades at $8.57 (market cap $1.05B). The key difference: BIO-TECHNE Corp is far larger — about 10.8× Upwork Inc's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while Upwork Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold BIO-TECHNE Corp for 63 Days and Upwork Inc for 38 Days on average.
| TECH | UPWK | |
|---|---|---|
Market Cap | $11.37B | $1.05B |
Volume | 3,153,511 | 2,250,109 |
Sector | Health | Industrials |
52-Week High | $72.61 | $22.11 |
52-Week Low | $43.31 | $7.84 |
Typical Hold Time | 63 Days | 38 Days |
Enterprise Value | $11.40B | $811.77M |
Dividend Yield | 0.44% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TECH trades at $72.53, near its 52-week high of $72.70, with a bullish technical signal and strong institutional interest. Recent earnings show mixed results, beating in Q2 2026 but missing in Q1. The company maintains solid profitability with a 65.77% gross margin, though net income declined to $73.40M in 2025. Shareholders approved an acquisition by Merck KGaA at $73.00 per share, a key near-term catalyst.
Outlook is positive due to the pending acquisition, but risks include execution challenges and valuation concerns with a high P/E of 62.53. Analyst consensus is divided with 46% buy ratings, suggesting cautious optimism. The stock offers limited upside to the acquisition price, making it suitable for event-driven investors.
UPWK trades at $8.57, up 2.51% today, with a bearish technical signal from moving averages and a neutral RSI. The company reported Q2 2026 earnings that beat EPS estimates but missed revenue expectations, with revenue growth slowing to 2.3% year-over-year in 2025. Recent news highlights insider selling by executives in September 2026 and ongoing securities fraud investigations, creating investor uncertainty despite a low P/E of 10.77 and strong gross margin of 77.21%.
The stock presents a mixed outlook: valuation metrics appear attractive with a consensus price target of $9.64, but risks include AI disruption to freelance demand, declining active clients, and legal overhangs. Near-term performance hinges on Q3 2026 earnings and management's ability to navigate competitive pressures, with institutional buying by Bank of America offering some support amid bearish technical trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About Upwork Inc
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with highly-skilled independent professionals. The develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to Clients.
Read more on UPWK →
